The T-cell receptor, which recognizes antigen plus a product of the major histocompatibility complex, has been postulated to drive T-cell maturation in the thymus by engaging major histocompatibility complex proteins expressed on thymic stromal cells. We tested this idea by injecting neonatal animals with an anti-receptor antibody, KJ16, that binds to about 20% of T cells and is capable of blocking receptor function. In the presence of this antibody, mature T cells bearing the KJ16 epitope failed to develop. On the other hand, although the antibody could be shown to bind to receptors on cortical thymocytes, it did not prevent the rapid expansion or survival of the bulk of the KJ16+ cells in this population. These results are consistent with the hypothesis that most cortical thymocytes arise by a receptor-independent mechanism and that only a small proportion of these cells mature by a process dependent on receptor-major histocompatibility complex interactions. With the discovery of the T-cell receptor for antigen, several laboratories have examined thymocytes both for the expression of the immunoglobulin-like genes that encode the a and f3 chains of the receptor and for the appearance of the receptor protein in an attempt to shed some light on the question of MHC restriction (7-11). Data support the view that stem cells enter the thymus with both the a and P3 chain genes in germ-line configuration. They rearrange and express sequentially first the /3-chain genes, then the a-chain genes. In the present study we have attempted to block the function of T-cell receptors in the thymus with an antireceptor antibody to test directly the hypothesis that engagement of the receptor by MHC products plays a crucial role in T-cell maturation. This antibody, administered to newborn mice, had no apparent effect on the bulk of receptor-bearing cortical thymocytes, but prevented the appearance of mature KJ16+ medullary thymocytes or peripheral T cells. These results demonstrate the importance of the receptor in thymocyte maturation but suggest that only a small proportion of cortical thymocytes is involved in receptor-mediated selection.
T-cell receptors for antigen, although similar to immunoglobulins, are distinguished by a combining site that recognizes antigen only when it has become associated on a cell surface with one of the products of the genes of the major histocompatibility complex (MHC), a phenomenon termed MHC restriction (1, 2) . Furthermore, during T-cell development in the thymus, a severe selection takes place such that the final repertoire of receptors that emerges is able to recognize antigen associated only with products of those MHC alleles that were expressed on the stromal cells in the thymus of the individual in which they developed (3, 4) . This phenomenon has implied a critical interaction between T-cell receptors and thymic MHC products during T-cell differentiation, in which only cells whose receptors engage MHC proteins are selected for maturation. Since in the periphery these cells will eventually recognize antigen plus MHC products rather than MHC products alone, understanding this thymic process at the molecular level has been a great challenge to immunologists.
There is, in fact, a great deal known about T-cell thymic development independent of the issue of self-MHC restriction (reviewed in refs. 5 and 6). Histological experiments both in the developing fetal thymus and in the steady-state adult thymus have supported the view that a small number of stem cells produced in the bone marrow (or fetal liver) enter the thymus and expand to give rise to an unresponsive and phenotypically distinct population found primarily in the thymic cortex. These cells make up the bulk of thymocytes and are frequently referred to as "immature" thymocytes because of their failure to respond detectably to antigen plus MHC or allo-MHC. Eventually some cortical thymocytes, either selected representatives ofthe predominant population or another as yet undefined subset, mature to give rise both to the medulla of the thymus and to the mature T cells found in the periphery. Numerous cell surface markers have been used to define and separate "immature" and mature thymocyte populations, as defined by the ability to respond functionally. The mature cells are phenotypically nearly indistinguishable from peripheral T cells.
With the discovery of the T-cell receptor for antigen, several laboratories have examined thymocytes both for the expression of the immunoglobulin-like genes that encode the a and f3 chains of the receptor and for the appearance of the receptor protein in an attempt to shed some light on the question of MHC restriction (7) (8) (9) (10) (11) (20) .
RESULTS

Rationale. The anti-receptor antibody KJ16-133 (KJ16)
detects at least two of the three members of the V,38 family (12) . In BALB/c and C57BL/6 mice, this epitope is found on the receptors expressed by about 15-20% of mature medullary or of peripheral T cells, including those of either the L3T4 or the Lyt2 phenotype (7). About 8-12% of thymic cortical cells bear KJ16+ receptors (7) . Assuming a similar proportion of KJ16+ receptors as seen among mature T cells, about 50-70% of cortical cells can be calculated to bear surface receptor. A consistent property of these cortical cells is that the number of surface receptors per positive cell is lower by a factor of 5-10 than on mature T cells (7) . In this study we have used this transition from low to high expression of KJ16+ receptor as our primary marker for distinguishing immature from mature T cells.
To test the hypothesis that engagement of the receptor is crucial to thymocyte differentiation, we attempted to block selectively the differentiation of KJ16+ T cells by in vivo administration of the antibody. Numerous functional studies have shown that KJ16 blocks antigen/MHC recognition by T-cell clones and hybridomas expressing KJ16+ receptors (13) , so that it was reasonable to assume it would block receptor function in the thymus. We chose the newborn mouse as the earliest stage easily accessible for in vivo administration of the antibody. Our experiments (7) had established that these animals had an expanding, but fully developed, thymic cortex with a proportion of cells that expressed the KJ16 epitope at a low level that was not significantly different from that of adult thymic cortex. Mature cells that expressed the KJ16 epitope at a high level increase from less than 1% at birth to about 2-3% of adult thymocytes. We predicted that KJ16 should block the development of mature KJ16+ thymocytes and, depending on the stage in differentiation when receptor-mediated interactions begin, might also cause a rapid depletion of KJ16+ cells from the expanding cortical pool.
Kinetics of Postnatal Development of Receptor Expression. Preliminary studies in untreated animals established the kinetics of appearance of cells that expressed the KJ16 epitope at a high level in both the thymus and spleen after birth (Table 1) . Although the number of cells in the thymus increased significantly after birth, the proportion of cells expressing a low level of the KJ16 epitope remained constant at about 10% (data not shown). The proportion of thymocytes with a high level of KJ16+ epitope, however, increased gradually to adult levels over several weeks. There was a parallel increase in the number of mature T cells in the periphery, with a relatively constant proportion of KJ16+ cells of about 20%. These results indicated that most thymus maturation and essentially all seeding of mature cells in the periphery takes place after birth.
Pepsin-Digested KJ16 Inhibits the Appearance of Mature Thymocytes. Mice were given daily injections i.p. of pepsintreated KJ16 or PBS from birth. After 8-25 days, thymocytes, and in some cases lymph node cells, were examined for KJ16 epitope expression. All groups were healthy. Thymocyte and peripheral T-cell numbers and the distribution of antigens such as Thy-i, Lyt2, and L3T4 developed normally in the treated mice (data not shown). This effect on the bulk of thymocytes and T cells was expected, since KJ16 reacts with only 20% of the T-cell receptors. However, there was a dramatic and selective effect of the antibody on cells expressing the KJ16 epitope. Results from mice sacrificed at 18 days are shown in Fig. 1 .
The typical staining pattern of adult lymph node and thymus cells from untreated mice is shown in Fig. 1 A and B . The KJ16+ T cells in the lymph node consistently showed a uniform high level of expression. The thymocytes included immature cells with low levels of KJ16 epitope and, in this experiment, about 3% with mature high level expression. Fig.  1C shows the staining of thymocytes from mice injected from birth with PBS. They were indistinguishable from the control thymocytes except for a somewhat lower percentage of mature cells typical for this age. Fig. 1D shows the staining pattern of thymocytes from mice injected from birth with KJ16. The treatment had no effect on the frequency of cells with a low level of KJ16 epitope expression. However, penetration of the antibody into the cortex was indicated both by the full staining of these cells with the secondary anti-K chain reagent alone and by a decrease in receptor density indicating partial modulation of the receptor. These results indicate that the receptor does not play a role in the maintenance of the majority of the KJ16+ cells in the thymic cortex. Furthermore, since there is considerable turnover and increase in the number of thymic cortical cells during this period, the receptor appears to play no role in their expansion. By contrast, treatment with the antibody prevented almost entirely the appearance after birth of mature thymocytes with a high level of KJ16 expression.
Since this mature population is such a small proportion of the total thymus, we obtained more quantitative data by treating some of the injected mice with cortisone two days prior to sacrifice and analysis. This treatment has been shown to destroy the immature cells of the thymus cortex and enrich for the mature cells in the surviving medulla (5). This method also allowed us to look at much younger mice. Data from animals sacrificed at 8 days are shown in Fig. 2 . As predicted, thymocytes from cortisone-treated control mice contained only mature KJ16+ cells with high levels of epitope ( Fig. 2A) a factor of 10 ( Fig. 2B) , although the total number of steroid-resistant cells was not significantly lowered.
Results similar to those in Figs. 1 and 2 were obtained with times of treatment as long as 25 days after birth, the latest time point examined. The lack of development ofmature cells was confirmed by the absence of KJ16+ T cells in the periphery of these animals as well (data not shown).
These results indicate that the bulk of thymic cortical cells do not arise from a receptor-mediated event nor do they require the receptor for their maintenance. They also support the conclusion that blocking the receptor with antibody prevents thymocyte maturation. However, there were a number of other possible explanations for the lack of mature KJ16+ cells in the treated animals. Therefore, we performed a series of control experiments in an attempt to eliminate some of these other possibilities.
Absence Fig. 3. Fig. 3 A and B shows thymocytes from control and KJ16-treated mice. Antibody penetrated the thymus and partially bound to sites on both immature and mature cells (Fig. 3B, secondary Fig. 1 . Thy-l' cells were found in similar numbers in nodes from control and antibody-treated animals (55% and 58%, respectively). In vivo exposure to monovalent anti-receptor antibody markedly decreases the mature thymocyte population reactive with the antibody. C57BL/6 mice were injected from birth with PBS or Fab' KJ16. Two animals from each group were sacrificed after 11 days. Two additional animals from each group were given cortisone acetate i.p. 48 hr prior to sacrifice at 11 days. Staining and analysis were performed as described in Fig. 1 antibody or F(ab')2 fragments. Because ofthe expected lower avidity and in vivo half-life of the Fab' fragment, we injected neonatal mice twice daily with amounts of antibody in excess of the available sites. After 11 days, the thymuses were removed and examined for KJ16-epitope expression. The data are presented in Fig. 4 . At this time control thymocytes showed a normal proportion of low-level KJ16-epitopeexpressing cortical thymocytes and a very small proportion of cells with high-level mature expression (Fig. 4A) . Cortisone treatment enriched for these mature cells (Fig. 4B) . Treated animals had the same amount of low-level-staining KJ16+ immature cells. The effect of the Fab' antibody on the appearance of mature cells could be quantitated at this early stage only in cortisone-treated animals (Fig. 4D) . In this case, despite the reduced efficiency of the antibody, a 75% reduction of high-level-staining KJ16+ mature cells was seen. These results strengthened our conclusion that KJ16 inhibition of the appearance of mature cells was related to its effect on the function of the receptor rather than to some Fcmediated elimination of the cells. They also argued against a mechanism of elimination that might involve signaling caused by receptor cross-linking (see Discussion). DISCUSSION
The most striking finding in our studies was that the KJ16 antibody had no effect in vivo on the bulk of cortical thymocytes. This finding is relevant both to the long-standing controversy over the precise pathway of thymocyte development and to various hypotheses concerning the role of interaction with MHC products in T-cell development. There is much evidence that most cells generated in the thymic cortex die there without maturing (6 death of the bulk of cortical thymocytes is attributed to the eventual elimination of self-tolerance of cells whose receptors fail to make the transition from recognition of MHC alone to recognition of antigen plus MHC (see below). Our data presented here and previously (7, 8) support a third point of view between these two extremes. Our estimates that 50-70% of cortical cells express surface receptor argues against the notion that the bulk of the cortical cells are doomed because they have failed to rearrange functional a and /8 genes. However, in the present study the fact that interference with the receptor on these cells did not alter their numbers or expansion also argues strongly that these cells are not primarily a population selected for anti-self-MHC specificities. Rather our results are consistent with the hypothesis that cortical cells arise by a nonspecific mechanism and represent the random expression of the receptor repertoire encoded in the germ line. The relatively few cells whose receptors are specific for self-MHC are selected for maturation by interaction with stromal cell MHC proteins, but the large majority of cortical cells die eventually because they are not selected. Our results do not directly address the question of the phenotype of these immediate precursors of mature thymocytes, other than to imply that these cells must bear surface receptor that can bind our anti-receptor antibody.
There are several other pieces of evidence that support this view. Kruisbeek et al. (14, 15) have performed experiments similar to ours, but using anti-Ia antibodies to block thymocyte maturation. Again, in this case, although T cells of the class that recognizes antigen plus Ia MHC proteins failed to develop in the treated animals, no effect was seen on the bulk of thymocytes indicating that interaction with Ia MHC proteins is not required for expansion of the major cortical thymocyte population. The ultrastructural studies of Farr et al. (16) in fact used KJ16 antibody to identify thymocytes within the cortex whose surface receptors were tightly associated with adjacent stromal epithelial cell membranes. However, the frequency of these cells was very low, far below the high frequency of surface KJ16+ cells detected cytofluorometrically in the cortex, suggesting that the bulk of receptor-bearing cortical thymocytes are not using their receptors to interact with stromal MHC proteins.
Although, as predicted, administering anti-receptor antibody to newborn mice prevented the appearance of mature T cells, the interpretation of this finding is not completely straightforward. Our favored interpretation is that blocking receptor interaction with MHC proteins in the thymus deprives the developing T cells of the critical selective signal required for maturation, a conclusion consistent with the findings of Kruisbeek et al. (14, 15) , with anti-Ia antibodies. We have, however, considered other interpretations of our results. The facts that mature cells already formed were not depleted by short-term treatment with the antibody and that a pure Fab' antibody was almost as effective in preventing mature cell development argue strongly against some trivial immunological mechanism being involved in the elimination of the mature cells after they are formed.
Another interpretation, more difficult to rule out formally, (18, 19) . Therefore, at present it is still possible that both blocking of selection and mimicking of tolerance contribute to the effects of antireceptor antibody in the thymus. In summary, the most striking conclusion of this study is that a large proportion of the cells in the thymus appear and expand without the requirement for receptor engagement. The cells involved in receptor-mediated MHC selection, therefore, must be infrequent. The challenge now is to find ways to identify and purify this small population.
